Emcure Pharmaceuticals IPO: The mainboard initial public offering (IPO) of leading pharma major Emcure Pharmaceuticals Ltd will open for subscription on Wednesday, July 3, 2024. The company develops, manufactures, and markets a wide range of pharmaceutical products across several major therapeutic areas. Emcure Pharma’s product portfolio consists of injectables, biotherapeutics, […]